TP53 and liver cancer: Notably, KLF5 exhibited a significant cell migration-inhibitory effect in the context of p53 knock-down in both HepG2 and BEL-7402 cells (Figure 2(c)), which confirmed that p53 status determined the effect of KLF5 on liver cancer cell migration, possibly through EMT regulation.